Ranibizumab assisted 23G vitrectomy for proliferative diabetic retinopathy

zhang hui,ye bo,qiu xinwen,lan lixia,ren xuan,liu wei
DOI: https://doi.org/10.13389/j.cnki.rao.2014.0270
2014-01-01
Abstract:Objective To investigate the efficacy of 23 G vitrectomy assisted with preoperative intravitreal injection of ranibizumab for proliferative diabetic retinopathy. Methods A retrospective analysis of 87 cases(89 eyes) with proliferative diabetic retinopathy treated by 23 G vitrectomy from January 2012 to December 2013 was performed. From January 2012 to December2012,92 cases( 92 eyes) with proliferative diabetic retinopathy treated only by 23 G vitrectomy as non-injected group(group A),and from January 2013 to December 2013,82 cases(86 eyes)with proliferative diabetic retinopathy treated by 23 G vitrectomy assisted with preoperative intravitreal injection of ranibizumab as injected group(group B). The operative time,hemorrhage during the operation,incidence of iatrogenic retinal hole,postoperative complications and postoperative visual acuity between the two groups were compared. Results The operation time in group A was(116. 22 ± 17. 46)minutes,group B was(80. 49 ± 18. 11)minutes,the difference was statistically significant( P < 0. 05). Hemorrhage during the operation were observed in 20 eyes in group A(21. 7%) and 4 eyes in group B(4. 6%)( χ2= 5. 563,P < 0. 05). The risk of iatrogenic retinal hole of group A and group B were 24 eyes(26. 1%) and 4 eyes(4. 7%),respectively(χ2= 7. 704,P < 0. 05). In postoperative follow-up period,there was no cases re-bleeding in the group B,but there were 4 eyes in the group A,and needed vitrectomy once more. The visual acuity in group A was HM-0. 3 and group B was HM-0. 5,the difference was not statistically significant(P > 0. 05),but there were statistical differences in preoperative and postoperative visual acuity between two groups(all P < 0. 05). Conclusion 23 G vitrectomy assisted with preoperative intravitreal injection of ranibizumab can decrease the operation time,reduce the incidence of intraoperative(iatrogenic retinal hole,bleeding) and postoperative complications in the treatment of proliferative diabetic retinopathy.
What problem does this paper attempt to address?